Bristol-Myers Squibb and Medical Engineering Corp.
This article was originally published in The Gray Sheet
Executive Summary
Named as defendants in a suit seeking class action status which alleges that the companies' silicone inflatable penile implants are "defective, prone to malfunction, and are unsafe for use in the human body," according to lawyers for the plaintiff. The suit, filed July 5 in federal court in Philadelphia, seeks damages and medical monitoring for patients who received the implants. In May, a similar case was filed in San Francisco against American Medical Systems and Pfizer regarding AMS silicone penile implants ("The Gray Sheet" May 23, p. 32)
You may also be interested in...
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.